Evaluation of the feasibility of digital health applications based on best practice guidelines for diabetes management: A scoping review

Abstract

Introduction

The prevalence of type 1 and type 2 diabetes mellitus has increased significantly and has become a major challenge for global healthcare systems. Digital health applications have emerged as potential solutions to improve diabetes management. However, many of these applications do not adhere to best practice standards, which can lead to patient rejection and application wastage.

Objective

This study aims to evaluate the feasibility of digital health applications based on best practice guidelines for diabetes management.

Methods

This study used the scoping review method to evaluate the feasibility of digital health applications based on best practice guidelines for diabetes management. The search strategy involved keywords relevant to diabetes mellitus and digital health applications, and searches were conducted in databases such as PubMed, Cochrane Library, EMBASE, and others. The collected data were analyzed descriptively to identify patterns, trends, and differences in application effectiveness.

Results

The results of this review indicate that some applications, such as mySugr PRO and Vitadio, adhere to best practice guidelines and have a significant positive impact on clinical parameters such as HbA1c levels. However, many other applications still fail to meet these standards, often due to a lack of relevant biomarker data and adherence to established guidelines.

Conclusion

The study concludes that while some digital health applications show promise in managing diabetes effectively, there is a need for improvement in many others to comply with best practice guidelines, which is crucial for maximizing their benefits and ensuring patient acceptance.